The MRC have released a new funding opportunity on tackling multimorbidity. This area of research has been identified as an urgent priority for the UK and globally following the Academy of Medical Sciences’ (AMS) report. Multimorbidity is defined as the co-existence of two or more chronic conditions in a single individual, including mental and physical conditions and long duration infectious diseases.
The objective of this funding call is to bring together world-leading multi-disciplinary expertise in epidemiological research, mechanistic and data science to catalyse multimorbidity research nationally and at scale through supporting portfolio of Research Collaboratives. There are two different streams available:
A pot of up to £1.5 million is available to support projects of 6 months duration with a maximum budget of £100k. Awards must be collaborative and multidisciplinary in nature and used to:
- Consolidate partnerships and bring in experts who might not traditionally view themselves at multimorbidity researchers.
- Perform rapid linkage and analyses of existing data including, for example, health data, population and environmental datasets.
- Obtain preliminary data or proof of principle evidence.
- Identify ket gaps that would be addressed at the full Research Collaborative stage.
- Verify their approaches towards addressing those gaps.
Research Collaborative Award
Research groups with more mature collaboration links; ownership or existing access to the relevant datasets; and sufficient evidence, unerpinned by strong preliminary data, of their ability to perform multimorbidity research at scale, can apply for the Wave 1 Research collaborative awards, bypassing the consolidator stage.
These awards will provide substantial investment to support ambitious studies (where appropriate involving industrial partners). The competition seeks to support a balanced potfolio of several Research Collaboratives for 2-4 years (£3-5m each).
Deadline for both streams: 11th February 2020, 4pm
For further details please visit the MRC website.